Contact us to place a job advertisement on this page
The British Journal of Pharmacology (BJP) is a broad-based journal giving leading international coverage of all aspects of experimental pharmacology. It publishes high quality original research and authoritative reviews and is published fortnightly. The British Pharmacological Society is seeking to appoint a new Editor-in-Chief to succeed Professor Ian McGrath who will complete a full term at the end of 2015. The Editor-in-Chief will be responsible for continuing to improve the quality of BJP, and driving new initiatives for the journal. The Editor-in-Chief will deliver strategic direction to the journal, and contribute more broadly to BPS’s publication strategy. View job description.
Please direct any questions regarding the recruitment process to Ruth Meyer (020 7417 0110, email@example.com). The deadline for applications is Monday 11 May 2015 and interviews will be held in the second week of June.
The British Journal of Clinical Pharmacology (BJCP) is a leading international clinical pharmacology journal, with an impact factor of 3.688. BJCP is published by Wiley and owned by the British Pharmacological Society (BPS). BJCP is looking to appoint a new European Senior Editor, and a new Australasian Editor (professionally based in those areas). The Editor-in-Chief (Professor Adam Cohen) is supported by six Senior Editors:
Professors Loke and Somogyi will demit after completing their full term of office. Senior Editors are responsible for initial triage of submissions, assignment of manuscripts to Executive Editors, taking the final accept/reject decision and communication with authors. Senior Editors also contribute to strategy and running of the journal via monthly teleconferences, and are asked to:
Senior Editors receive training on the ScholarOne submission system. We plan to appoint in June for a start date in July to allow a 6-month overlap and handover with the current Senior Editors. The initial appointment is for four years, with a possibility of year-on-year mutually agreed extensions to a maximum of seven years. This position is remunerated. Senior Editors are expected to be current members of the BPS, or willing to join the Society. Previous editorial experience is required.
BJCP’s broad range of coverage and its regional Senior Editorship appointment means that Senior Editors will oversee articles covering the breadth of the discipline of clinical pharmacology and not falling directly within their own specialised range of expertise, so candidates must be prepared to oversee all submissions irrespective of the area.
Interested applicants should send their CV, and a covering letter explaining their suitability for the role, to Ruth Meyer at BPS by Monday 18 May.
Interviews will be held (by teleconference) in mid June. For further information about BJCP please see: www.bjcp-journal.com
The William Harvey Research Institute is currently the UK’s largest academic pharmacological research institute and has a long history of training talented scientists for careers in translational research (www.whri.qmul.ac.uk). We are now seeking outstanding life sciences graduates for our MRC funded 1 year MRes programme in in vivo sciences to commence in October 2013. During the year students will obtain a comprehensive training in in vivo techniques, key laboratory skills, research governance, the application of state-of-the-art imaging techniques and generic transferable skills followed by an opportunity to conduct an in-vivo based research project. The highest ranking students may be offered the opportunity to build upon their MRes studies and conduct a fully-funded 3 year PhD within the WHRI with their chosen supervisor. For further information on the course visit their website.
All students will be based in the attractive Charterhouse Square campus in the City of London with access to exceptional scientific and recreational facilities.
This training will be an invaluable foundation for individuals wishing to pursue a career in industry or academic research, particularly in the areas of inflammation science, cardiovascular research or cell signaling. Successful applicants will receive an award covering tuition fees and a bursary at the current MRC rate for 1 year.
This studentship is funded by the Medical Research Council and comes with a tax-free stipend of £15, 863 per annum. This studentship is open to UK Nationals, EEA/Swiss migrant workers and non-UK nationals with indefinite leave to remain in the UK who all have three years ordinary residence in the UK prior to the start of the studentship.
Please also email a current copy of your CV to the course supervisor. Your referees should also email references directly to the course supervisors: Prof. Amrita Ahluwalia (firstname.lastname@example.org), Prof. Fulvio D’Acquisto (email@example.com) or Prof. Paul Chapple (firstname.lastname@example.org).
Interviews scheduled from the week beginning 9th June 2015. The closing date for applications is 29 May 2015.
The University of Adelaide is one of Australia’s leading Group of Eight, research-intensive universities and is consistently ranked among the top 1% of universities in the world. Established in 1874, it is Australia’s third oldest university with a strong reputation for preparing educated leaders and delivering research outcomes that contribute to local, national and global wellbeing.
The School of Medical Sciences encompasses the disciplines of Anatomy and Pathology, Pharmacology and Physiology. It is one of eight schools in the Faculty of Health Sciences. The School offers a supportive environment where students and staff are nurtured to reach their full potential and where excellence in research and teaching is fostered.
The Discipline of Pharmacology is currently seeking to appoint a Clinical Pharmacologist to coordinate and lead clinical pharmacology and therapeutics teaching within the undergraduate MBBS program and to oversee relevant clinical pharmacology and therapeutics content within the Dental and Nursing programs.
In this role, you will develop a successful research program in an area of pharmacology and therapeutics and, preferably, research areas that complement existing strengths in the School. In particular,research would target the Discipline of Pharmacology research strengths, which include clinical pharmacogenomics, drug metabolism and transport, neurogastroenterology, neuropharmacology of drug abuse, pain and molecular toxicology. You will be initially be located at the Medical School North building, prior to relocating in 2017 to the new Adelaide Medical and Nursing Schools (AMNS) building, whose research themes include the neurosciences and ageing and chronic diseases.
Term of position: This continuing position is available from 1 June 2015.
Salary: (Level E) $163,674 per annum or (Level D) $127,063 - $139,984 per annum, subject to thequalifications and experience of the successful applicant. Additional clinical loading of $28,330 applies.
Superannuation: An employer contribution of 17% applies.